GO
Loading...

Drug Retail

More

  • Auxilium Pharma accepts Endo's $1.67B buyout offer Thursday, 9 Oct 2014 | 10:42 AM ET

    Auxilium Pharmaceuticals agreed to be bought by Endo International, terminating its deal to buy Canadian eye-drug maker QLT.

  • Weed, Inc.: The business of legal marijuana     Thursday, 9 Oct 2014 | 7:00 AM ET

    Medical marijuana, which is legal in 23 states and Washington, D.C., and recreational marijuana -- legal in Colorado and Washington State -- bring dispensaries and states healthy revenues, via taxes and fees. Watch a 90-second overview of the business of legal marijuana by the numbers.

  • Oct 8- Canadian pharmacy chain Jean Coutu Group Inc reported a 3 percent rise in quarterly revenue as an increase in the number of franchised stores helped offset the impact of higher sales of generic drugs. Price-controls for generic drugs, aimed at cutting costs for government and private health programs, have also hurt Jean Coutu and rivals such as Shoppers...

  • Jean Coutu's sales rise 3 pct Wednesday, 8 Oct 2014 | 7:20 AM ET

    Oct 8- Canadian pharmacy chain Jean Coutu Group Inc reported higher quarterly sales, helped by demand for generic drugs and the expansion of its network of franchised stores. Net profit fell to C $53.6 million, or 28 Canadian cents per share, in the quarter ended Aug. 30, from C $208.2 million, or 99 Canadian cents per share, a year earlier. The company had reported a gain...

  • Oct 1- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said Walgreen Co would sell prescription drugs under its two Medicare Part D plans for 2015..

  • Sept 30- U.S. drugstore chain Walgreen Co said lower insurer payments for prescriptions amid increased competition, and a rise in generic drug prices would continue to hurt margins in the current quarter, pressing its shares. Pharmacy chains such as Walgreen are contracted with health insurers and others that operate Medicare Part D drug plans.

  • Sept 30- U.S. drugstore chain operator Walgreen Co reported its biggest jump in quarterly sales in three years, helped by higher prescription sales, sending its shares up more than 3 percent in premarket trading. Walgreen ended the year with a record 856 million filled prescriptions.

  • Sept 30- U.S. drugstore chain operator Walgreen Co reported a 6.2 percent rise in quarterly sales, helped by higher prescription sales, sending its shares up more than 3 percent in premarket trading.

  • Problems for potpreneurs     Wednesday, 24 Sep 2014 | 1:54 PM ET

    CNBC's Kate Rogers reports on the uphill battle facing potpreneurs.

  • Tekmira soars on FDA news     Monday, 22 Sep 2014 | 2:05 PM ET

    Tekmira said regulators in the U.S. and Canada authorized use of its experimental drug for Ebola through an expanded access program. CNBC's Meg Tirrell provides insight.

  • High at work     Thursday, 18 Sep 2014 | 1:54 PM ET

    A new survey from Mashable finds nearly 10 percent of Americans admit to smoking pot before heading into the office. CNBC's Kate Rogers shares the difficulties in testing employees.

  • Sept 18- Rite Aid Corp cut its full-year profit forecast for the second time in about three months due to lower margins in its pharmacy business, sending its shares down more than 16 percent.

  • Sept 18- Rite Aid Corp, the third-largest U.S. drugstore chain, cut its full-year profit forecast for the second time, citing lower margins in its pharmacy business, sending its shares down 11 percent in premarket trading.

  • Rite Aid cuts full-year profit forecast for second time Thursday, 18 Sep 2014 | 7:27 AM ET

    Sept 18- Rite Aid Corp, the third largest U.S. drugstore chain, cut its full-year profit forecast for the second time this year as lower margins from its pharmacy business continue to eat into earnings. Rite Aid shares fell nearly 9 percent in premarket trading on Thursday after the company also shaved the top end of its sales forecast.

  • Avanir up on Alzheimer's trial     Monday, 15 Sep 2014 | 1:03 PM ET

    Avanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO Keith Katkin.

  • Orexigen's obesity pill     Thursday, 11 Sep 2014 | 1:11 PM ET

    Orexigen's obesity pill is called Contrave, and it's been approved in the U.S. CNBC's Meg Tirrell reports.

  • Food prices hit 4-year low, Russia ban hurts Thursday, 11 Sep 2014 | 8:20 AM ET

    The UN food price index has dipped to a four-year low as good weather has resulted in an oversupply of cereals and dairy imports have slowed.

  • Walgreen adds activist hedge fund founder to board Monday, 8 Sep 2014 | 7:57 AM ET
    Barry Rosenstein, founder and managing partner of Jana Partners

    Walgreen is naming Jana founder Rosenstein to its board and the activist investor will get a say in choosing at least one additional director.

  • BISMARCK, N.D., Sept 4- North Dakota's oil boom has fueled a construction bonanza for new supermarkets, restaurants and clothing stores. But try finding a Rite Aid, Walgreens or other national pharmacy chain in the state, the fastest-growing economy in the nation, and you'll be largely out of luck.

  • Aug 22- Pharmacy chain Walgreen Co suffered a system outage for several hours on Friday, taking all of its 8,200 pharmacy outlets offline and delaying prescription orders. The company faced a "technical issue" during a system update and had to bring the entire system offline to resolve it, spokesman Michael Polzin said.